Outset Medical, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| OM | 49Z.F | QLIFE.ST | 6118.HK | MODD | INFU | |
|---|---|---|---|---|---|---|
| Market cap | 83.46M | 154.56M | 26.07M | 274.23M | 15.86M | 261.91M |
| P/E (TTM) | — | — | — | 13.4 | — | 32.9 |
| Forward P/E | -1.9 | — | -5.0 | — | -3.3 | 25.3 |
| Price/book | 0.9 | 0.1 | 9.8 | 0.3 | 0.9 | 4.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −66.96% | +7.89% | −52.43% | −48.54% | −89.08% | +28.00% |
| Today | +6.99% | +3.30% | −9.61% | +0.94% | −5.65% | +2.73% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All OM news ›Rheinmetall AG Unsponsored ADR (OTCMKTS:RNMBY) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages
Posted by Mitch Edgeman on Nov 1st, 2026 Rheinmetall AG Unsponsored ADR (OTCMKTS:RNMBY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the company,…
Outset Medical, Inc. (NASDAQ:OM) Stock Has Average Target Price of $10.00 According to Brokerages
Posted by Kim Johansen on Oct 27th, 2026 Several research analysts have recently issued reports on OM shares. Wall Street Zen raised Outset Medical from a “sell” rating to a “hold” rating in a research note on Saturday, August 15th. Weiss…
RWS’s (RWS) “Buy” Rating Reiterated at Berenberg Bank
Posted by Danessa Lincoln on Oct 27th, 2026 RWS (LON:RWS – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Berenberg Bank in a note issued to investors on Tuesday, MarketBeat reports. They currently have…
MDxHealth: Bleichroeder reports 32.04% stake
MDxHealth SA (MDXH) is a precision diagnostics company focused on molecular tests for prostate cancer and other urologic diseases, using genomic and epigenetic technologies. - [SCHEDULE 13D/A] MDxHealth SA Amended Major Shareholder Report…
Pulsenmore: Aquamarine reports 5.02% passive stake
A passive holder reports more than 5% of Pulsenmore (PLSM) ordinary shares. Stock Titan - [SCHEDULE 13G] Pulsenmore Ltd. Passive Investment Disclosure (>5%) Pulsenmore: Aquamarine reports 5.02% passive stake Aquamarine reported sole voting…
Outset Medical: BML reports 14.7% passive stake
A partnership reports shared voting power over 2.76M Outset Medical (OM) shares. Stock Titan - [SCHEDULE 13G/A] Outset Medical, Inc. Amended Passive Investment Disclosure Outset Medical: BML reports 14.7% passive stake The reported…
Outset Medical: BML buys 228,334 shares on October 1
Outset Medical, Inc. (NASDAQ: OM) is a medical technology manufacturer focused on the Tablo Hemodialysis System to simplify dialysis across hospital and home care. - [Form 4] Outset Medical, Inc. Insider Trading Activity Outset Medical:…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com4
- stocktitan.net3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.